DE602005019547D1 - "verfahren und zwischenprodukte zur herstellung von statinen; insbesondere von rosuvastatin" - Google Patents
"verfahren und zwischenprodukte zur herstellung von statinen; insbesondere von rosuvastatin"Info
- Publication number
- DE602005019547D1 DE602005019547D1 DE200560019547 DE602005019547T DE602005019547D1 DE 602005019547 D1 DE602005019547 D1 DE 602005019547D1 DE 200560019547 DE200560019547 DE 200560019547 DE 602005019547 T DE602005019547 T DE 602005019547T DE 602005019547 D1 DE602005019547 D1 DE 602005019547D1
- Authority
- DE
- Germany
- Prior art keywords
- formula
- compound
- group
- protecting
- protecting group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/30—Oxygen atoms, e.g. delta-lactones
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Steroid Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0406757A GB0406757D0 (en) | 2004-03-26 | 2004-03-26 | Process and compounds |
PCT/GB2005/001099 WO2005092867A2 (en) | 2004-03-26 | 2005-03-23 | Process and intermediate compounds useful in the preparation of statins, particularly rosuvastatin |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602005019547D1 true DE602005019547D1 (de) | 2010-04-08 |
Family
ID=32188702
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE200560019547 Active DE602005019547D1 (de) | 2004-03-26 | 2005-03-23 | "verfahren und zwischenprodukte zur herstellung von statinen; insbesondere von rosuvastatin" |
Country Status (21)
Country | Link |
---|---|
US (2) | US8703945B2 (de) |
EP (2) | EP1729775B1 (de) |
JP (1) | JP5016478B2 (de) |
KR (1) | KR20060130765A (de) |
CN (1) | CN101022807B (de) |
AT (2) | ATE458484T1 (de) |
AU (1) | AU2005225602A1 (de) |
BR (1) | BRPI0507999A (de) |
CA (1) | CA2561059C (de) |
CY (2) | CY1110091T1 (de) |
DE (1) | DE602005019547D1 (de) |
DK (2) | DK1729775T3 (de) |
ES (2) | ES2379481T3 (de) |
GB (1) | GB0406757D0 (de) |
HR (1) | HRP20100287T1 (de) |
IL (1) | IL178274A0 (de) |
PL (2) | PL1729775T3 (de) |
PT (2) | PT1729775E (de) |
RS (1) | RS51306B (de) |
SI (2) | SI1729775T1 (de) |
WO (1) | WO2005092867A2 (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100349877C (zh) | 2001-07-13 | 2007-11-21 | 阿斯特拉曾尼卡英国有限公司 | 氨基嘧啶化合物的制备方法 |
GB0218781D0 (en) | 2002-08-13 | 2002-09-18 | Astrazeneca Ab | Chemical process |
GB0312896D0 (en) | 2003-06-05 | 2003-07-09 | Astrazeneca Ab | Chemical process |
GB0324791D0 (en) | 2003-10-24 | 2003-11-26 | Astrazeneca Ab | Chemical process |
GB0406757D0 (en) * | 2004-03-26 | 2004-04-28 | Avecia Ltd | Process and compounds |
GB0427491D0 (en) | 2004-12-16 | 2005-01-19 | Avecia Ltd | Process and compounds |
CN101208307B (zh) * | 2005-06-24 | 2012-10-17 | 力奇制药公司 | 制备不含杂质的无定型罗苏伐他汀钙的方法 |
EP1978020A1 (de) * | 2007-04-03 | 2008-10-08 | LEK Pharmaceuticals D.D. | Verfahren zur Herstellung von Statinen, insbesondere von Rosuvastatin, und Zwischenprodukt für deren Herstellung |
US8183397B2 (en) | 2007-04-03 | 2012-05-22 | Lek Pharmaceuticals D.D. | Synthesis of statins |
CA2713009C (en) | 2008-01-23 | 2018-08-28 | Lek Pharmaceuticals D.D. | ((2s,4r)-4,6-dihydroxytetrahydro-2h-pyran-2-yl)methyl carboxylate and process for the production thereof |
AU2013202895B2 (en) * | 2009-03-10 | 2014-09-18 | Redx Pharma Plc | Rosuvastatin and atorvastatin derivatives |
GB0904102D0 (en) * | 2009-03-10 | 2009-04-22 | Bradford Pharma Ltd | Use of atorvastatin lactols as medicaments |
GB0904100D0 (en) * | 2009-03-10 | 2009-04-22 | Bradford Pharma Ltd | Use of rosuvastatin lactols as medicaments |
GB0904104D0 (en) * | 2009-03-10 | 2009-04-22 | Bradford Pharma Ltd | Atorvastatin and rosuvastatin derivatives |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4474971A (en) * | 1982-09-29 | 1984-10-02 | Sandoz, Inc. | (Tetrahydropyran-2-yl)-aldehydes |
US4625039A (en) * | 1983-12-21 | 1986-11-25 | Sandoz Pharm. Corp. | 4-trisubstituted silyl protected hydroxy-6-oxo-tetrahydropyran-2-yl-aldehyde intermediates |
US4677211A (en) | 1984-06-29 | 1987-06-30 | Sandoz Pharmaceuticals Corp. | Preparation of lactones |
JP2648897B2 (ja) | 1991-07-01 | 1997-09-03 | 塩野義製薬株式会社 | ピリミジン誘導体 |
US5795749A (en) | 1995-04-05 | 1998-08-18 | The Scripps Research Institution | Use of 2-deoxyribose-5-phosphate aldolase to prepare 2-deoxyfucose, analogues and derivatives |
GB9903472D0 (en) | 1999-02-17 | 1999-04-07 | Zeneca Ltd | Chemical process |
WO2001022962A1 (en) * | 1999-09-30 | 2001-04-05 | Merck & Co., Inc. | Anti-hypercholesterolemic drug combination |
GB0003305D0 (en) | 2000-02-15 | 2000-04-05 | Zeneca Ltd | Pyrimidine derivatives |
GB0011163D0 (en) * | 2000-05-10 | 2000-06-28 | Astrazeneca Ab | Chemical compound |
CA2459926A1 (en) | 2001-09-24 | 2003-04-03 | Merck & Co., Inc. | Screening and selection methods for statin drug combinations |
DE10216967A1 (de) | 2002-04-16 | 2003-11-13 | Bayer Ag | Verfahren zur Herstellung spezieller aromatischer Aldehyde |
US7371759B2 (en) | 2003-09-25 | 2008-05-13 | Bristol-Myers Squibb Company | HMG-CoA reductase inhibitors and method |
WO2005040134A1 (en) * | 2003-10-22 | 2005-05-06 | Ranbaxy Laboratories Limited | Process for the preparation of amorphous rosuvastatin calcium |
DE10352659B4 (de) | 2003-11-11 | 2007-09-13 | Ratiopharm Gmbh | Verfahren zur Herstellung von Statinen und Tetrahydropyranonderivate zur Verwendung in dem Verfahren |
GB0406757D0 (en) * | 2004-03-26 | 2004-04-28 | Avecia Ltd | Process and compounds |
-
2004
- 2004-03-26 GB GB0406757A patent/GB0406757D0/en not_active Ceased
-
2005
- 2005-03-23 DK DK05731809T patent/DK1729775T3/da active
- 2005-03-23 JP JP2007504474A patent/JP5016478B2/ja not_active Expired - Fee Related
- 2005-03-23 CA CA 2561059 patent/CA2561059C/en not_active Expired - Fee Related
- 2005-03-23 WO PCT/GB2005/001099 patent/WO2005092867A2/en active Application Filing
- 2005-03-23 EP EP20050731809 patent/EP1729775B1/de active Active
- 2005-03-23 DE DE200560019547 patent/DE602005019547D1/de active Active
- 2005-03-23 KR KR20067021900A patent/KR20060130765A/ko not_active Application Discontinuation
- 2005-03-23 ES ES08157487T patent/ES2379481T3/es active Active
- 2005-03-23 ES ES05731809T patent/ES2341658T3/es active Active
- 2005-03-23 PL PL05731809T patent/PL1729775T3/pl unknown
- 2005-03-23 BR BRPI0507999-3A patent/BRPI0507999A/pt not_active Application Discontinuation
- 2005-03-23 US US10/594,380 patent/US8703945B2/en not_active Expired - Fee Related
- 2005-03-23 RS RSP20100217 patent/RS51306B/sr unknown
- 2005-03-23 CN CN2005800096821A patent/CN101022807B/zh not_active Expired - Fee Related
- 2005-03-23 SI SI200531001T patent/SI1729775T1/sl unknown
- 2005-03-23 PT PT05731809T patent/PT1729775E/pt unknown
- 2005-03-23 AT AT05731809T patent/ATE458484T1/de active
- 2005-03-23 DK DK08157487T patent/DK1958633T3/da active
- 2005-03-23 AT AT08157487T patent/ATE536875T1/de active
- 2005-03-23 SI SI200531491T patent/SI1958633T1/sl unknown
- 2005-03-23 PL PL08157487T patent/PL1958633T3/pl unknown
- 2005-03-23 EP EP20080157487 patent/EP1958633B1/de not_active Not-in-force
- 2005-03-23 PT PT08157487T patent/PT1958633E/pt unknown
- 2005-03-23 AU AU2005225602A patent/AU2005225602A1/en not_active Abandoned
-
2006
- 2006-09-25 IL IL178274A patent/IL178274A0/en unknown
-
2010
- 2010-05-21 HR HR20100287T patent/HRP20100287T1/hr unknown
- 2010-05-21 CY CY101100456T patent/CY1110091T1/el unknown
-
2012
- 2012-03-14 CY CY20121100274T patent/CY1115040T1/el unknown
-
2014
- 2014-03-25 US US14/225,018 patent/US9024025B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE602005019547D1 (de) | "verfahren und zwischenprodukte zur herstellung von statinen; insbesondere von rosuvastatin" | |
BR0109922A (pt) | Compostos quìmicos | |
ATE364651T1 (de) | Polymerisationskatalysator für polyester, damit hergestellter polyester und verfahren zur herstellung von polyester | |
ATE444747T1 (de) | Verfahren zur herstellung von expoxybutanol- zwischenprodukten | |
DE502005001385D1 (de) | Verfahren zur herstellung von aminen aus carbodiimidgruppen aufweisenden verbindungen durch hydrolyse mit wasser | |
ATE377593T1 (de) | 9,10-alpha,alpha-oh-taxananaloga und verfahren zu deren herstellung | |
ATE442363T1 (de) | Verfahren zur herstellung von pyridinverbindungen | |
DE60309251D1 (de) | Verfahren zur Herstellung von Donepezil | |
ATE524505T1 (de) | Polymerisierbare zusammensetzung und flachdruckplattenvorläufer damit, alkalilösliches polyurethanharz sowie verfahren zur herstellung einer diolverbindung | |
DE60125378D1 (de) | Verfahren zur herstellung von 2-aminomethyl-halogen-pyridinen | |
DE602006012622D1 (de) | Verfahren zur herstellung von 1,1,1-tris(4-hydroxyphenyl)alkanen | |
ATE492523T1 (de) | Verfahren zur herstellung von halogensubstituiertem benzoldimethanol | |
DK1598358T3 (da) | Forbindelser indeholdende 3,4-methylendioxythiophen-enheder | |
ATE393187T1 (de) | Verfahren zur modifizierung eines fluorpolymersubstrats und dadurch erhaltene verbundgegenstände | |
DE602005022213D1 (de) | Verfahren zur herstellung von phenyl-2-pyrimidinyl-ketonen und neuen zwischenprodukten daraus | |
ATE444323T1 (de) | Neuartige epoxidverbindungen und verfahren zu ihrer herstellung | |
ATE279422T1 (de) | Verfahren zur herstellung von 1-hydroxy-1, 1- diphosphonsäureverbindungen | |
ATE293095T1 (de) | Verfahren zur herstellung von cyclopropancarboxylaten | |
DE60141724D1 (de) | Methode zur Herstellung von Diazaphosphacyclen | |
DE602004031727D1 (de) | Neues verfahren und zwischenprodukte zur herstellung von 19-nor-steroiden | |
DE502006002384D1 (de) | Verfahren zur herstellung von tetracarbonsäuren | |
DE60306361D1 (de) | Verfahren zur herstellung von benazeprilhydrochloride | |
DE602004023633D1 (de) | Verfahren zur herstellung von 2,3,6,7,10,11-hexahydroxytriphenylen | |
ATE375335T1 (de) | Verfahren zur herstellung von n-glycidylaminen | |
DE602005001507D1 (de) | Verfahren zur herstellung von diiminverbindungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8327 | Change in the person/name/address of the patent owner |
Owner name: BRADFORD PHARMA LTD., WIGAN, LANCASHIRE, GB |
|
8364 | No opposition during term of opposition | ||
R082 | Change of representative |
Ref document number: 1729775 Country of ref document: EP Representative=s name: PATENTANWAELTE FREISCHEM, 50677 KOELN, DE |